That New Alzheimer’s Drug? Don’t Get Your Hopes Up Yet by GINA KOLATA

By GINA KOLATA

After declaring aducanumab a failure, the manufacturer now says the drug may help slow cognitive decline in certain patients. Some experts are skeptical.

Published: October 21, 2019 at 08:00PM

from NYT Health https://ift.tt/2MZm4JG
via IFTTT

from WordPress https://ift.tt/2BFLZRb
via IFTTT